- Home
- FRSX vs INAB Comparison
FRSX vs INAB Comparison
Compare FRSX & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- INAB
- Stock Information
- Founded
- FRSX N/A
- INAB 2016
- Country
- FRSX Israel
- INAB United States
- Employees
- FRSX N/A
- INAB N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- INAB Health Care
- Exchange
- FRSX Nasdaq
- INAB Nasdaq
- Market Cap
- FRSX 7.0M
- INAB 7.5M
- IPO Year
- FRSX 2017
- INAB 2021
- Fundamental
- Price
- FRSX $0.36
- INAB $2.26
- Analyst Decision
- FRSX
- INAB Strong Buy
- Analyst Count
- FRSX 0
- INAB 2
- Target Price
- FRSX N/A
- INAB $108.00
- AVG Volume (30 Days)
- FRSX 411.5K
- INAB 92.2K
- Earning Date
- FRSX 08-15-2025
- INAB 08-07-2025
- Dividend Yield
- FRSX N/A
- INAB N/A
- EPS Growth
- FRSX N/A
- INAB N/A
- EPS
- FRSX N/A
- INAB N/A
- Revenue
- FRSX $452,000.00
- INAB N/A
- Revenue This Year
- FRSX N/A
- INAB N/A
- Revenue Next Year
- FRSX N/A
- INAB N/A
- P/E Ratio
- FRSX N/A
- INAB N/A
- Revenue Growth
- FRSX N/A
- INAB N/A
- 52 Week Low
- FRSX $0.31
- INAB $1.98
- 52 Week High
- FRSX $2.63
- INAB $17.64
- Technical
- Relative Strength Index (RSI)
- FRSX 42.21
- INAB 47.63
- Support Level
- FRSX $0.35
- INAB $2.10
- Resistance Level
- FRSX $0.40
- INAB $2.46
- Average True Range (ATR)
- FRSX 0.03
- INAB 0.14
- MACD
- FRSX 0.00
- INAB 0.02
- Stochastic Oscillator
- FRSX 58.14
- INAB 56.12
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.